Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from EXACT Therapeutics AS ( (DE:56F) ) is now available.
EXACT Therapeutics AS announced its participation in the DNB Carnegie Nordic Healthcare Conference, where it will present a company update. This engagement underscores the company’s commitment to advancing its innovative drug delivery technology, potentially enhancing its industry position and offering significant implications for stakeholders in oncology and related fields.
More about EXACT Therapeutics AS
EXACT Therapeutics AS is a clinical-stage precision medicine company that leverages ultrasound and microbubbles for targeted drug delivery in oncology. Their Acoustic Cluster Therapy (ACT®) is designed to enhance the efficacy of various therapeutic agents, including chemotherapy and immunotherapy, and can be applied to multiple indications such as brain diseases.
Average Trading Volume: 45,897
Current Market Cap: NOK120.2M
Learn more about 56F stock on TipRanks’ Stock Analysis page.